Patents Represented by Attorney Fulbright & Jaworski L.L.P.
  • Patent number: 8322906
    Abstract: Systems and methods which provide a versatile lighting module which may be utilized alone or in combination with other lighting modules to provide any number of lighting unit configurations are shown. Lighting modules of embodiments herein are adapted to facilitate electrical connection, whether to one or more power supply and/or to one or more other lighting module, along any portion of the entire periphery of the lighting module. Accordingly, lighting modules may be coupled together in any orientation, geometry, and topology to cooperate as a light source having various desired characteristics according to embodiments herein.
    Type: Grant
    Filed: August 8, 2011
    Date of Patent: December 4, 2012
    Assignee: XtraLight Manufacturing Partnership Ltd
    Inventors: Jerry H. Caroom, Jr., Ken McAlpin, Luis E. Anker, Jason H. Lynch
  • Patent number: 8323904
    Abstract: A kit and a method are provided for easily measuring the concentration of an active ingredient of a termite insecticide persisting in soil, particularly on site where a termite insecticide was actually applied. A kit of the present invention comprises 1) an extraction unit for extracting, with an solvent, a termite insecticide active ingredient from an object of measurement and 2) a reaction unit including a reaction container for encapsulating an identifying antigen, a fixing member for immobilizing an antibody against an active ingredient, and a sealing member capable of fitting to the reaction container. The kit optionally includes 3) a detection unit for visually or optically detecting a change depending on the concentrations of the active ingredient in the object of measurement, and 4) a dilution unit for diluting the sample solution to a certain ratio.
    Type: Grant
    Filed: December 14, 2006
    Date of Patent: December 4, 2012
    Assignee: Bayer Cropscience AG
    Inventors: Shiro Miyake, Mikiko Uchigashima, Atsushi Kadowaki
  • Patent number: 8326330
    Abstract: A method and apparatus for updating configuration attributes by transmitting a FastRepage Attribute in a wireless communication system is provided, comprising generating a FastRepage Attribute comprising an 8 bit Length field wherein the Length field indicates a value of length of the FastRepage attribute in octets excluding the length of Length field, an 8 bit AttributeID field, an 8 bit FastRepageEnabled field wherein the FastRepageEnabled field is set to a value ‘0x01’ to indicate that FastRepage is enabled and a 16 bit FastRepageInterval field, wherein the FastRepageInterval field indicates a value of interval at which an access network pages an access terminal when the access network does not receive a response to a page and transmitting the FastRepage attribute over a communication link. A method and apparatus is further provided for receiving and processing the FastRepage attribute.
    Type: Grant
    Filed: October 27, 2006
    Date of Patent: December 4, 2012
    Assignee: Qualcomm Incorporated
    Inventors: Rajat Prakash, Fatih Ulupinar, Gavin Horn
  • Patent number: 8324359
    Abstract: The present invention concerns oxocarbonamide peptide nucleic acids (OxoPNAs). OxoPNAs provide increased stability, sensitivity, and specificity as compared to their natural DNA and RNA counterparts. The OxoPNA molecules of the present invention may be employed in a wide range of applications, particularly in applications involving hybridization. For example, OxoPNA probes may be employed for the detection and functional analysis of nucleic acid molecules, including miRNAs and other non-coding RNAs.
    Type: Grant
    Filed: November 29, 2007
    Date of Patent: December 4, 2012
    Assignee: Luminex Corporation
    Inventors: Ananda G. Lugade, James W. Jacobson
  • Patent number: 8323665
    Abstract: The present invention provides methods to produce toxoid vaccines, such as ricin A chain vaccines, with reduced ability to promote vascular leak syndrome (VLS) and catalytic toxicity associated with various proteinaceous toxins, such as ribosome inactivating proteins. The invention also provides toxoids which have been mutated to lack amino acid sequences which induce VLS and toxic catalytic activity.
    Type: Grant
    Filed: February 12, 2007
    Date of Patent: December 4, 2012
    Assignee: The Board of Regents of the University of Texas System
    Inventors: Ellen S. Vitetta, Victor F. Ghetie, Joan E. Smallshaw, Roxana G. Baluna
  • Patent number: 8326307
    Abstract: The present invention relates to systems and methods for a multi-cell deployment model of a wireless backhaul network that implements frequency reuse. The backhaul network includes a plurality of cells, each of which includes a center hub supporting wireless backhaul communication over four geographic sectors. A first tier of the plurality of cells includes a center cell configured to support a first alternating frequency reuse pattern of a first channel and a second channel over four corresponding geographic sectors. A second tier of the plurality of cells surrounds the first tier. The second tier includes a first cell configured to support the first alternating reuse pattern over four corresponding geographic sectors, and wherein the first cell is horizontally adjacent to the center cell.
    Type: Grant
    Filed: November 19, 2010
    Date of Patent: December 4, 2012
    Assignee: Taqua WBH, LLC
    Inventors: Seyed Mohammad Ali Arad, Frank van Heeswyk
  • Patent number: 8323638
    Abstract: Disclosed is a method of treating a wound comprising applying a composition to a wound site on a patient in need of wound treatment, wherein the composition comprises mitotically inactive allogeneic cells that secrete one or more biologically active molecules selected from the group consisting of GM-CSF, VEGF, KGF, bFGF, TGF?, angiopoietin, EGF, IL-I?, IL-6 IL-8, TGF?, and TNF?, and wherein the cells are keratinocytes or fibroblasts, or mixtures thereof.
    Type: Grant
    Filed: February 8, 2012
    Date of Patent: December 4, 2012
    Assignee: DFB Technology Holdings, LLC
    Inventors: Eric Rolland, Thomas Hunziker, Beatrice Mis, Christopher Rinsch
  • Patent number: 8324358
    Abstract: Block copolymers labelled with molecular recognition units and comprising a hydrophobic block and a luminescent block are presented. A method of detecting biomolecules using such block copolymers is also presented. More specifically, the block copolymers of the present invention have the following Formula (I): wherein “A” is a hydrophobic block; “B” is a luminescent block; “C” is a hydrophilic block; “D” is a molecular recognition unit; “n” and “m” are integers ranging from 1 to 75; “x” is either 0 or an integer ranging from 1 to 75; and “Y” is either 0 or 1.
    Type: Grant
    Filed: May 26, 2006
    Date of Patent: December 4, 2012
    Assignee: McGill University
    Inventors: Hanadi Sleiman, Bingzhi Chen, Kim Metera
  • Patent number: 8323734
    Abstract: A Fabry-Perot filter is applied as a thin coating on a film, for example, a packaging film, and permits interesting color effects. The coating has a layered construction in which both reflecting layers of the filter may be made of aluminum and the intermediate layer between the reflecting layers may be made of aluminum oxide.
    Type: Grant
    Filed: December 9, 2010
    Date of Patent: December 4, 2012
    Assignee: Applied Materials GmbH & Co. KG
    Inventors: Gerd Hoffmann, Rainer Ludwig, Hans-Georg Lotz, Gerhard Steiniger
  • Patent number: 8318445
    Abstract: The present invention relates to methods and systems for labeling, isolating, detecting, and/or enumerating a statistically significant number of biological cells, or other biological analytes of interest, present in a complex matrix sample. The isolation of a biological target of interest from a sample mixture is done by immunomagnetic separation. Upon introduction of the sample within an imaging chamber, the capture complex (biological target-magnetic capture agent) will be attracted by the magnetic field and will lay on the surface of the chamber in the focal plane of the imaging system.
    Type: Grant
    Filed: January 7, 2009
    Date of Patent: November 27, 2012
    Assignee: Luminex Corporation
    Inventors: Bruce J-C Bernard, Kurt D. Hoffacker, Charles J. Collins
  • Patent number: 8318918
    Abstract: The present invention relates to an isolated nucleic acid molecule, comprising a nucleotide sequence, which encodes a polypeptide with chalcone 3-hydroxylase activity, wherein the nucleotide sequence comprises SEQ ID NO. 1 or has at least a 60% identity with SEQ ID NO. 1 or is able to hybridize with a molecule comprising the sequence of SEQ ID NO. 1, wherein the nucleotide sequence encodes a polypeptide, which comprises the motif FASRPLSX1X2G(X3)m(GSAGGD)n (SEQ ID NO. 3), wherein X1 is threonine or serine, X2 is alanine or glycine, X3 is any amino acid, m is an integer between 50 and 200, and n is 0 or 1.
    Type: Grant
    Filed: December 31, 2009
    Date of Patent: November 27, 2012
    Assignee: Technische Universitat Wien
    Inventors: Heidrun Halbwirth, Karin Schlangen, Karl Stich
  • Patent number: 8320940
    Abstract: A mobile access point is disclosed. The mobile access point includes a terminal module configured to provide one or more terminal functions for use by a user, the one or more terminal functions including a voice or data communications application, and a gateway module configured to provide one or more gateway functions for use by at least one client device, the one or more gateway functions including providing the at least one client device access to a computer network, and a processor configured to execute the terminal module and the gateway module to effectuate their corresponding functions.
    Type: Grant
    Filed: August 4, 2008
    Date of Patent: November 27, 2012
    Assignee: Qualcomm Incorporated
    Inventors: Liren Chen, Jack Steenstra, Kirk Steven Taylor
  • Patent number: 8318786
    Abstract: Azelaic acid or its derivatives or analogs induce a robust and a speedier defense response against pathogens in plants. Azelaic acid treatment alone does not induce many of the known defense-related genes but activates a plant's defense signaling upon pathogen exposure.
    Type: Grant
    Filed: August 14, 2008
    Date of Patent: November 27, 2012
    Assignees: The University of Chicago, UT-Battelle, LLC
    Inventors: Jean T. Greenberg, Ho Won Jung, Timothy Tschaplinski
  • Patent number: 8318245
    Abstract: The invention relates to a method for producing an optical article having antireflection or reflective properties and comprising a substrate having at least one main surface, comprising the step of depositing an sub-layer onto a substrate's main surface, the step of treating the sub-layer by ionic bombardment and the step of depositing onto said sub-layer a multilayered stack comprising at least one high refractive index layer and at least one low refractive index layer. According to a preferred embodiment, the deposition of the sub-layer is conducted in a vacuum chamber in which a gas is supplied during the deposition step.
    Type: Grant
    Filed: February 22, 2008
    Date of Patent: November 27, 2012
    Assignee: Essilor International (Compagnie Generale d'Optique)
    Inventors: Philippe Roisin, Michèle Thomas
  • Patent number: 8318810
    Abstract: A composition comprising a novel Ca2+-activated, [ATP]i-sensitive nonspecific cation (NCCa-ATP) channel is described. The channel is found in mammalian neural cells and exhibits a different sensitivity to block by various adenine nucleotides, and is activated by submicromolar [Ca]i. The NCCa-ATP channel is activated under conditions of ATP depletion, which causes severe cell depolarization, followed by cell swelling. The NCCa-ATP channel is regulated by a sulfonylurea receptor and is inhibited by sulfonylurea compounds glibenclamide and tolbutamide. Methods employing compositions comprising the NCCa-ATP channel to screen for compounds that block the channel and the use of such antagonists as therapeutics in preventing brain swelling and damage are described. In addition, methods employing compositions comprising the Kir2.3 channel to screen for compounds that open the channel and the use of such antagonists as therapeutics in preventing brain swelling and damage are described.
    Type: Grant
    Filed: September 19, 2007
    Date of Patent: November 27, 2012
    Assignees: University of Maryland, Baltimore, The United States of America as represented by the Department of Veterans Affairs
    Inventors: J. Marc Simard, Mingkui Chen
  • Patent number: 8318222
    Abstract: Disclosed is a multi-beneficial topical skin care composition, and methods for its use, that can hydrate skin, increase the firmness of skin, reduce the appearance of fine lines or wrinkles on skin, and reduce the appearance of age spots on skin. The composition can include a combination of skin active ingredients comprising euterpe oleracea fruit extract, punica granatum sterols, caprooyl tetrapeptide-3, tocopherol or tocopherol acetate, and niacinamide, a combination of skin moisturizing agents comprising glycerin and butyrospermum parkii, a photo stable combination of sunscreen agents providing the composition with a sun protection factor (SPF) of at least about 15, and a dermatologically acceptable vehicle which imparts a non-greasy feel when applied to skin.
    Type: Grant
    Filed: February 8, 2011
    Date of Patent: November 27, 2012
    Assignee: Mary Kay, Inc.
    Inventors: Michelle Hines, Greg Norman
  • Patent number: 8318178
    Abstract: A topical skin care composition and method for its use comprising Codium tomentosum extract and Crithmum maritimum extract, wherein the composition is formulated as an emulsion, cream, lotion, solution, gel, ointment, or anhydrous base.
    Type: Grant
    Filed: December 20, 2011
    Date of Patent: November 27, 2012
    Assignee: Mary Kay, Inc.
    Inventor: Gopa Majmudar
  • Patent number: 8316480
    Abstract: A preferred embodiment of the present invention comprises a mobile cantilever transfer device for transferring mobility-impaired patients. In one embodiment, the mobile cantilever transfer device includes a support surface that is cantilevered from a lift cart so that the support surface may be positioned over the origination or destination location for a transfer, such as a patient's bed. In yet another embodiment, the cantilevered support surface may be laterally extended from the lift cart in order to allow the support surface to be positioned at different points over a transfer location without moving the lift cart. In yet another embodiment, multiple sides of the support surface may be connected to the lift cart so that a transfer can be accomplished from multiple directions, such as on either side of a patient's bed.
    Type: Grant
    Filed: December 11, 2008
    Date of Patent: November 27, 2012
    Assignee: Technimotion, LLC
    Inventors: William E. Burak, Jr., Frederic Palay
  • Patent number: 8312924
    Abstract: The invention relates to methods and apparatuses for the subterranean injection of reactive substances like propellants into wellbores and subterranean reservoirs. These methods and apparatuses controls the temperature of a reactive substance for safe handling at surface and controls the decomposition rate of the substances in the subterranean environment. In addition, these methods and apparatuses provide a means for safe dilution of reactive fluids in the event of a leak or spillage of the reactive substance.
    Type: Grant
    Filed: April 15, 2009
    Date of Patent: November 20, 2012
    Inventor: David Randolph Smith
  • Patent number: D671836
    Type: Grant
    Filed: August 2, 2011
    Date of Patent: December 4, 2012
    Assignee: Mary Kay Inc.
    Inventor: Jenny DeMarco